Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Endocr J. 2013;60(7):855-9. doi: 10.1507/endocrj.ej13-0024. Epub 2013 Mar 9.
Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10% of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.
家族性糖皮质激素缺乏症(FGD)是一种罕见的常染色体隐性遗传病,其特征为原发性低皮质醇血症和正常的盐皮质激素产生。最近,编码烟酰胺核苷酸转氢酶的 NNT 已被确定为 FGD 的致病基因。因此,我们在六个日本 FGD 患者中检查了 NNT,这些患者在先前已知的四个 FGD 相关基因(MC2R、MRAP、STAR 和 MCM4)中没有可识别的突变,并且在一个 17.5 岁的男孩中发现了一个新的纯合子替换(c.644T>C;p.Phe215Ser)。他的父母对此突变是杂合的。该替换在 120 名日本对照中不存在,也未在包括 JSNP 数据库在内的公共数据库中注册。第 215 位密码子处的苯丙氨酸残基在进化上是保守的,并且通过计算机蛋白质功能分析评估 p.Phe215Ser 为病理性突变。这些结果与之前的数据一起表明,NNT 突变占 FGD 患者的 5-10%,而在相当一部分 FGD 患者中,潜在的因素仍有待阐明。